Specific Nanozyme-Based Cascade Catalysis Hydrogel With Oxygen-Self-Supplying and ROS-Scavenging Capacity for Efficient Diabetic Wound Healing.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 41906528.
- Also identified by DOI 10.1002/adhm.202505890.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Diabetic wounds are characterized by impaired and delayed healing due to a pathological triad of hyperglycemia, excessive reactive oxygen species (ROS) accumulation, and persistent tissue hypoxia. Herein, a glucose-activated cascade catalysis oxygen-self-supplying hydrogel (M/G gel) is developed by co-embedding glucose oxidase (GOx) and a catalase-mimicking molybdenum-based specific nanozyme (MF) into a biocompatible chitosan/sodium alginate hydrogel matrix. The M/G gel system initiates a glucose-responsive cascade reaction: GOx oxidizes glucose to produce H<sub>2</sub>O<sub>2</sub>, the resultant and endogenous H<sub>2</sub>O<sub>2</sub> is then selectively decomposed by MF into H<sub>2</sub>O and O<sub>2</sub>, enabling simultaneous glycemic control, ROS scavenging and hypoxia alleviation. In vitro studies demonstrate that MF exhibits potent antioxidant activity, sustained O<sub>2</sub> generation, and promotes the cell migration. In vivo results disclose that M/G gel accelerates diabetic wound healing by facilitating M1-to-M2 macrophage polarization switch, reducing HIF-1α expression, enhancing CD31-mediated angiogenesis, and restoring extracellular matrix deposition. Moreover, the hydrogel system shows excellent biocompatibility and biosafety. This work presents a rationally engineered, self-regulated cascade catalysis platform with great potential for the treatment of diabetic wounds and other ROS- and hypoxia-related diseases.